HomeCompareILDR vs JNJ

ILDR vs JNJ: Dividend Comparison 2026

ILDR yields 6.72% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ILDR wins by $11.2K in total portfolio value
10 years
ILDR
ILDR
● Live price
6.72%
Share price
$29.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.2K
Annual income
$1,029.28
Full ILDR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ILDR vs JNJ

📍 ILDR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodILDRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ILDR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ILDR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ILDR
Annual income on $10K today (after 15% tax)
$570.85/yr
After 10yr DRIP, annual income (after tax)
$874.89/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ILDR beats the other by $171.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ILDR + JNJ for your $10,000?

ILDR: 50%JNJ: 50%
100% JNJ50/50100% ILDR
Portfolio after 10yr
$25.6K
Annual income
$928.53/yr
Blended yield
3.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ILDR
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ILDR buys
0
JNJ buys
0
No recent congressional trades found for ILDR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricILDRJNJ
Forward yield6.72%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.2K$20.0K
Annual income after 10y$1,029.28$827.78
Total dividends collected$8.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ILDR vs JNJ ($10,000, DRIP)

YearILDR PortfolioILDR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,372$671.59$10,676$355.77+$696.00ILDR
2$12,881$713.74$11,407$389.39+$1.5KILDR
3$14,539$755.61$12,198$426.53+$2.3KILDR
4$16,353$797.04$13,056$467.62+$3.3KILDR
5$18,336$837.87$13,987$513.12+$4.3KILDR
6$20,498$877.99$14,998$563.56+$5.5KILDR
7$22,850$917.28$16,098$619.52+$6.8KILDR
8$25,405$955.65$17,295$681.69+$8.1KILDR
9$28,176$993.00$18,599$750.82+$9.6KILDR
10$31,178$1,029.28$20,022$827.78+$11.2KILDR

ILDR vs JNJ: Complete Analysis 2026

ILDRStock

The First Trust Innovation Leaders ETF (the "Fund") seeks to provide capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in common stock and depository receipts issued by U.S. and non-U.S. companies that may benefit from the development or application of scientific and technological innovation. This includes, but is not limited to, companies that are poised to benefit from new products or services, scientific research, technological improvements and/or enhancements to existing products or services related to automation, advanced medicine, networks, advanced computing, enhanced mobility, energy revolution and e-commerce.

Full ILDR Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ILDR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ILDR vs SCHDILDR vs JEPIILDR vs OILDR vs KOILDR vs MAINILDR vs ABBVILDR vs MRKILDR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.